Drugs / WSK-IM05
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07565740 | May 2026 → May 2027 expected | oropharynx squamous cell carcinoma | West China Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WSK-IM05 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07565740 ↗ |
| Modality | Vaccine | “Intranasal recombinant adenovirus vaccine WSK-IM05” NCT07565740 ↗ |
| Route | Intranasal | “administered via nasal spray” NCT07565740 ↗ |